| Colleen Duggan Weber, OTR/L | |
|
2506 Sky View Ln, Laramie, WY 82070-5378 | |
| (307) 760-4145 | |
| Not Available |
| Full Name | Colleen Duggan Weber |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2506 Sky View Ln, Laramie, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811177900 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTR-976 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Colleen Duggan Weber, OTR/L 2506 Sky View Ln, Laramie, WY 82070-5378 Ph: (307) 760-4145 | Colleen Duggan Weber, OTR/L 2506 Sky View Ln, Laramie, WY 82070-5378 Ph: (307) 760-4145 |
News Archive
Despite decades of advances in diabetes care, African Americans and Latinos are still far less likely than whites to have their blood sugar under control, even with the help of medications, a new nationally representative study finds.
Isilon® Systems today announced that The Translational Genomics Research Institute has deployed Isilon scale-out NAS as the primary storage solution powering its next-generation biomedical research. By using Isilon IQ to power multiple genome sequencing devices, TGen has unified its mission-critical operations onto a single, high-performance, highly scalable shared pool of storage, increasing workflow productivity and reducing costs to accelerate the discovery of new treatments for life-threatening diseases.
Smoking during pregnancy has many adverse effects on fetal development.
Five-year data from the Asthma Intervention Research 2 clinical trial presented today demonstrated that the Boston Scientific Corporation Alair Bronchial Thermoplasty System continues to show therapy benefits in adult patients with severe uncontrolled asthma.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced initiation of patient enrollment in the second Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) in hemodialysis patients with secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease.
› Verified 8 days ago
Tyler Ann Burton, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1771 Centennial Dr, Ste. 220, Laramie, WY 82070 Phone: 307-742-3571 | |
Elsa Pope, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1771 Centennial Dr, Laramie, WY 82070 Phone: 307-742-3571 | |
Kelly Ann Demshar, MOT, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 503 S 18th St, Laramie, WY 82070 Phone: 402-957-3541 | |
Mrs. Mary Collins Guenzel, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1150 N 3rd St, Laramie, WY 82072 Phone: 307-742-6641 Fax: 307-742-9203 | |
Ms. Patricia Ann Casey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Laramie Care Center, 503 S. 18th St., Laramie, WY 82070 Phone: 307-742-3728 | |
Samantha Bauer, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1771 Centennial Dr, Laramie, WY 82070 Phone: 307-742-3571 | |
Ark Regional Services, Inc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1150 N 3rd Street, Laramie, WY 82072 Phone: 307-742-6641 Fax: 307-742-9203 |